spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Flovent 

 HSMN NewsFeed - 17 Aug 2020
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Biopharmaceuticals Drug Delivery Generics Distribution
 HSMN NewsFeed - 27 Jan 2020
Ninety Percent of Patients Can't Use Inhalers Correctly, Digital Inhaler CapMedic Receives FDA Clearance to Change That
Devices Drug Delivery FDA
 HSMN NewsFeed - 3 Apr 2013
Aquinox Pharmaceuticals Completes US $18 million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Jul 2012
Glaxosmithkline Concludes Previously Announced Agreement in Principle to Resolve Multiple Investigations with US Government and Numerous States
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 23 Sep 2008
Oriel Therapeutics Appoints Richard Fuller as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 23 Jul 2008
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2008
Neuromed Names Sean Cunliffe Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2008
CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2006
FDA Approves REYATAZ(R) (atazanavir sulfate) 300 mg Single Capsule Formulation in Combination Therapy for Adults With HIV-1 Infection
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 11 Oct 2006
GSK Submits Supplemental Drug Application for Advair in COPD
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
Flovent
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.